Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient

Lorenzo Gallon*, D. Chhabra

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient'. Together they form a unique fingerprint.

Medicine & Life Sciences